Here are relevant reports on : occupational-health-services-market
-
Brain Computer Interface Market by Product (Non-invasive, Invasive, Partial invasive), Technology (EEG, MEG, ECoG, fMRI), Application (Disability/Rehabilitation, Assistive technologies, Mental health, Research), End User - Global Forecast to 2029
The global brain computer interface market, valued at US$235 million in 2023, stood at US$262 million in 2024 and is projected to advance at a resilient CAGR of 14.1% from 2024 to 2029, culminating in a forecasted valuation of US$506 million by the end of the period. The growth of this market is driven by the growing incidence & prevalence of neurological disorders, increasing demand for non-invasive and wearable brain computer interface devices, and rising Investments in research and development.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Fashion Accessory Market - By Type (Home, Sports, Office, Health care), Product (Consumer electronics, Automotive, Entertainment, Fashion), Application (Mobile Phones, PCs, Wearable Electronics), Geography - Analysis & Forecast (2014 - 2020)
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Health Ingredients Market by Type (Vitamins, Minerals, Probiotics starter culture, Prebiotics, Nutritional Lipids, Functional Carbohydrates, Plant and Fruit Extracts, Enzymes, Proteins), Application, Source, Function and Region - Global Forecast to 2027
The market for health ingredients is projected to reach USD 146.3 billion by 2027, it is projected to grow at a CAGR of 7.8% during the forecast period. The key players in this market include Archer Daniels Midland Company (ADM) (US), Associated British Foods PLC (UK), International Flavors & Fragrances Inc. (US), Kerry Group PLC (Ireland), DSM (Netherlands), BASF SE (Germany), Cargill Incorporated (US), Ingredion (US), Arla Foods (Denmark), Tate & Lyle (UK), Lonza (Switzerland), Royal FrieslandCampina N.V. (Netherlands), Glanbia PLC (Ireland), CHR Hansen Holdings A/S, (Denmark), and Probi (Sweden). Strategic partnerships were the dominant strategy adopted by the key players, followed by expansions and new product launches. These strategies have helped them to increase their presence in different regions and industrial segments.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Gluten-free Baking Mixes Market by Application (Cookies, Cakes and Pastries, Bread, Pizza, Others), Distribution Channel (Supermarkets & Hypermarkets, Health Food Stores, Convenience & Grocery Stores, Others) and Key Region - Forecasted to 2027
According to MarketsandMarkets, the global Gluten-free baking mixes market is estimated to be valued at USD 477.1 million in 2022. It is projected to reach USD 681.7 million by 2027, with a CAGR of 7.4%, in terms of value between 2022 and 2027. Growth of gluten-free baking mixes market size is expected to be driven by rising awareness around gluten intolerance, with governments approving the gluten-free labels to raise such awareness amongst consumers.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Pilot Health Monitoring Systems Market by Component (Hardware, Software) by Platform (Commercial, Defense) by Implementation (On-premises, Cloud-based) by Sales Channel (OEM, Aftermarket) and Region - Global Forecast to 2030
The major players in the global Pilot Health Monitoring Systems Market
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Udder Health Market by Product (Pharmaceuticals (Antibiotics, Intramammary Infusions), Devices (Milk Quality Analysers), Supplements)), Veterinary Care Settings (Dairy Farms, Veterinary Hospitals & Clinics), Animal Type - Global Forecast to 2029
The global udder health market, valued at US$1.13 billion in 2023, stood at US$1.18 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$1.58 billion by the end of the period. The growth in the udder health market can be attributed to the factors, including increasing investments, funds, and grants by governments and other organizations, rising number of veterinarians in the developing countries.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Vitamin K2 Market by Application (Health Supplements, Functional Food & Beverages, Pharmaceutical), Product Type (MK-7, MK-4), Application Form (Capsules & Tablets, Powder & Crystalline, Liquids), Source, Function, and Region - Global Forecast to 2031
The Vitamin K2 market is estimated to be USD 179.0 million in 2026 and is projected to reach USD 339.9 million by 2031, at a CAGR of 13.7% from 2026 to 2031. The report profiles key players such as Gnosis by Lesaffre (France), Balchem Corp (US), J-OIL MILLS, INC (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Menadiona (Spain), GF Fermentech (South Korea), AngelYeast Co., Ltd. (China), and GeneFerm Biotechnology Co., Ltd. (Taiwan).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets – (Pharmaceuticals, Medical devices and Health insurance)
The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders.
- Published: August 2010
- Price: $ 4950
- TOC Available:
-
Nutrigenomics Market: A boon to Human Health, Perspective by Applications and Geography - Global Trends and Forecasts up to 2017
As a result of globalization, the global population is being more health conscious. The ever increasing middleclass families also prefer the healthy diet and are more concerned towards nutrition. Thus the pioneering concept of Nutrigenomics has been boon for human health which provides a customized food which helps in optimum utilization of nutrients.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
